Spleen IL-10, a key player in obesity-driven renal risk

Nephrology Dialysis Transplantation

Volumn 28, Issue 5, 2013, Pages 1061-1064

  Spoto, Belinda ^a   Zoccali, Carmine ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADIPOCYTE; ADIPOSE TISSUE; ALBUMINURIA; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; INNATE IMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SPLEEN;

ANIMALS; DIET, HIGH-FAT; FEMALE; INFLAMMATION; INTERLEUKIN-10; MALE; OBESITY; RENAL INSUFFICIENCY, CHRONIC; SPLEEN; SPLENECTOMY;

EID: 84877994794     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft094     Document Type: Review

References (28)

1. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease. A systematic review and meta-analysis. Kidney Int 2008; 73: 19-33
2. Hall JE, Crook ED, Jones DW et al. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 2002; 324: 127-137
3. Rea DJ, Heinbach JK, Grande JP et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006; 70: 1636-1641
4. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867
5. Clement K, Langin D. Regulation of inflammation-related genes in human adipose tissue. J Intern Med 2007; 262: 422-430
6. Kim E. Insulin resistance at the crossroads of metabolic syndrome: systemic analysis using microarrays. Biotechnol J 2010; 5: 919-929
7. Aljada A, Mohanty P, Ghanim H et al. Increase in intranuclear nuclear factor kB and decrease in inhibitor kB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutrition 2004; 79: 682-690
8. Shi H, Kokoeva MV, Inouye K et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025
9. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor. Arterioscler Thromb Vasc Biol 2005; 25: 2062-2068
10. Wu Y, Liu Z, Xiang Z et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147: 44-50
11. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196
12. Serradeil-Le GC, Raufaste D, Brossard G et al. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett 1997; 404: 185-191
13. Han DC, Isono M, Chen S et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001; 59: 1315-1323
14. Sharma K, Ramachandrarao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118: 1645-1656
15. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301
16. de Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autore-gulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220
17. Olszyna DP, Pajkrt D, Lauw FN et al. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. J Infect Dis 2000; 181: 613-620
18. Wang P, Wu P, Siegel MI et al. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human mono-cytes. J Biol Chem 1995; 270: 9558-9563
19. Esposito K, Pontillo A, Giugliano F et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88: 1055-1058
20. Pinderski Oslund LJ, Hedrick CC, Olvera T et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999; 19: 2847-2853
21. Gunnett CA, Heistad DD, Berg DJ et al. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 2000; 279: H1555-H1562
22. Kitching AR, Katerelos M, Mudge SJ et al. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 2002; 128: 36-43
23. Mu W, Ouyang X, Agarwal A et al. IL-10 supresses chemokines, inflammation and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651-3660
24. Gotoh K, Inoue M, Masaki T et al. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 2012; 61: 1994-2003
25. Gotoh K, Inoue M, Masaki T et al. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrol Dial Transplant 2012; 27
26. Lauw FN, Pajkrt D, Hack CE et al. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000; 165: 2783-2789
27. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy: review of a new approach. Pharmacol Rev 2003; 55: 241-269
28. Poplawski MM, Mastaitis JW, Isoda F et al. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One 2011; 6: e18604